Enhancing docetaxel efficacy and reducing toxicity using biodegradable periodic mesoporous organosilica nanoparticles

Taxanes, such as docetaxel (DTX), are pivotal in cancer therapy, showcasing remarkable efficacy against various cancers, like breast, lung, and ovarian malignancies. However, DTX's efficacy is hindered by poor target specificity and significant adverse effects. Formulations containing DTX often...

Full description

Saved in:
Bibliographic Details
Main Authors: Ha Nguyen Van, Linh Ho Thuy Nguyen, Ngoc Xuan Dat Mai, Anh Ha Nhat, Trinh Le Thi Thu, Anh Nguyen Thi Bao, Ha Nguyen Thanh, Minh Tri Le, Tan Le Hoang Doan
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024161622
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846148900024483840
author Ha Nguyen Van
Linh Ho Thuy Nguyen
Ngoc Xuan Dat Mai
Anh Ha Nhat
Trinh Le Thi Thu
Anh Nguyen Thi Bao
Ha Nguyen Thanh
Minh Tri Le
Tan Le Hoang Doan
author_facet Ha Nguyen Van
Linh Ho Thuy Nguyen
Ngoc Xuan Dat Mai
Anh Ha Nhat
Trinh Le Thi Thu
Anh Nguyen Thi Bao
Ha Nguyen Thanh
Minh Tri Le
Tan Le Hoang Doan
author_sort Ha Nguyen Van
collection DOAJ
description Taxanes, such as docetaxel (DTX), are pivotal in cancer therapy, showcasing remarkable efficacy against various cancers, like breast, lung, and ovarian malignancies. However, DTX's efficacy is hindered by poor target specificity and significant adverse effects. Formulations containing DTX often include polysorbate 80 and ethanol, exacerbating reactions like hypersensitivity and neurological disorders. Nanotechnology offers a promising avenue to address these challenges, aiming to enhance DTX's targeted delivery and solubility. Mesoporous silica nanoparticles (MSN), notably biodegradable periodic organosilane (BPMO), have emerged as promising carriers due to their stability, biocompatibility, and drug-loading capacity. BPMO's intracellular biodegradability reduces the risk of toxic accumulation. Compared to conventional MSN, BPMO particles exhibit superior characteristics, including size, surface area, and DTX loading ability. Moreover, cell line studies suggest BPMO's potential to mitigate DTX-associated adverse effects. These findings highlight BPMO nanoparticles' potential in improving DTX delivery, solubility, and reducing adverse effects, underscoring their significance in cancer therapy.
format Article
id doaj-art-9e6b2a0842054b37a2ae1c77dd03716f
institution Kabale University
issn 2405-8440
language English
publishDate 2024-11-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-9e6b2a0842054b37a2ae1c77dd03716f2024-11-30T07:11:53ZengElsevierHeliyon2405-84402024-11-011022e40131Enhancing docetaxel efficacy and reducing toxicity using biodegradable periodic mesoporous organosilica nanoparticlesHa Nguyen Van0Linh Ho Thuy Nguyen1Ngoc Xuan Dat Mai2Anh Ha Nhat3Trinh Le Thi Thu4Anh Nguyen Thi Bao5Ha Nguyen Thanh6Minh Tri Le7Tan Le Hoang Doan8University of Health Science (UHS), VNU-HCM, Ho Chi Minh City, Viet Nam; Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam; Vietnam National University, Ho Chi Minh City, Viet NamUniversity of Health Science (UHS), VNU-HCM, Ho Chi Minh City, Viet Nam; Vietnam National University, Ho Chi Minh City, Viet NamCenter for Innovative Materials and Architectures (INOMAR), Ho Chi Minh City, Viet Nam; Vietnam National University, Ho Chi Minh City, Viet NamUniversity of Health Science (UHS), VNU-HCM, Ho Chi Minh City, Viet Nam; Vietnam National University, Ho Chi Minh City, Viet NamUniversity of Health Science (UHS), VNU-HCM, Ho Chi Minh City, Viet Nam; Vietnam National University, Ho Chi Minh City, Viet NamUniversity of Health Science (UHS), VNU-HCM, Ho Chi Minh City, Viet Nam; Vietnam National University, Ho Chi Minh City, Viet NamInstitute of Drug Quality Control Ho Chi Minh City (IDQC HCMC), Viet NamUniversity of Health Science (UHS), VNU-HCM, Ho Chi Minh City, Viet Nam; Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam; Vietnam National University, Ho Chi Minh City, Viet NamCenter for Innovative Materials and Architectures (INOMAR), Ho Chi Minh City, Viet Nam; Vietnam National University, Ho Chi Minh City, Viet Nam; Corresponding author. Center for Innovative Materials and Architectures (INOMAR), Ho Chi Minh City, Viet Nam.Taxanes, such as docetaxel (DTX), are pivotal in cancer therapy, showcasing remarkable efficacy against various cancers, like breast, lung, and ovarian malignancies. However, DTX's efficacy is hindered by poor target specificity and significant adverse effects. Formulations containing DTX often include polysorbate 80 and ethanol, exacerbating reactions like hypersensitivity and neurological disorders. Nanotechnology offers a promising avenue to address these challenges, aiming to enhance DTX's targeted delivery and solubility. Mesoporous silica nanoparticles (MSN), notably biodegradable periodic organosilane (BPMO), have emerged as promising carriers due to their stability, biocompatibility, and drug-loading capacity. BPMO's intracellular biodegradability reduces the risk of toxic accumulation. Compared to conventional MSN, BPMO particles exhibit superior characteristics, including size, surface area, and DTX loading ability. Moreover, cell line studies suggest BPMO's potential to mitigate DTX-associated adverse effects. These findings highlight BPMO nanoparticles' potential in improving DTX delivery, solubility, and reducing adverse effects, underscoring their significance in cancer therapy.http://www.sciencedirect.com/science/article/pii/S2405844024161622DocetaxelNanomaterialCancerDrug deliveryBPMOMSN
spellingShingle Ha Nguyen Van
Linh Ho Thuy Nguyen
Ngoc Xuan Dat Mai
Anh Ha Nhat
Trinh Le Thi Thu
Anh Nguyen Thi Bao
Ha Nguyen Thanh
Minh Tri Le
Tan Le Hoang Doan
Enhancing docetaxel efficacy and reducing toxicity using biodegradable periodic mesoporous organosilica nanoparticles
Heliyon
Docetaxel
Nanomaterial
Cancer
Drug delivery
BPMO
MSN
title Enhancing docetaxel efficacy and reducing toxicity using biodegradable periodic mesoporous organosilica nanoparticles
title_full Enhancing docetaxel efficacy and reducing toxicity using biodegradable periodic mesoporous organosilica nanoparticles
title_fullStr Enhancing docetaxel efficacy and reducing toxicity using biodegradable periodic mesoporous organosilica nanoparticles
title_full_unstemmed Enhancing docetaxel efficacy and reducing toxicity using biodegradable periodic mesoporous organosilica nanoparticles
title_short Enhancing docetaxel efficacy and reducing toxicity using biodegradable periodic mesoporous organosilica nanoparticles
title_sort enhancing docetaxel efficacy and reducing toxicity using biodegradable periodic mesoporous organosilica nanoparticles
topic Docetaxel
Nanomaterial
Cancer
Drug delivery
BPMO
MSN
url http://www.sciencedirect.com/science/article/pii/S2405844024161622
work_keys_str_mv AT hanguyenvan enhancingdocetaxelefficacyandreducingtoxicityusingbiodegradableperiodicmesoporousorganosilicananoparticles
AT linhhothuynguyen enhancingdocetaxelefficacyandreducingtoxicityusingbiodegradableperiodicmesoporousorganosilicananoparticles
AT ngocxuandatmai enhancingdocetaxelefficacyandreducingtoxicityusingbiodegradableperiodicmesoporousorganosilicananoparticles
AT anhhanhat enhancingdocetaxelefficacyandreducingtoxicityusingbiodegradableperiodicmesoporousorganosilicananoparticles
AT trinhlethithu enhancingdocetaxelefficacyandreducingtoxicityusingbiodegradableperiodicmesoporousorganosilicananoparticles
AT anhnguyenthibao enhancingdocetaxelefficacyandreducingtoxicityusingbiodegradableperiodicmesoporousorganosilicananoparticles
AT hanguyenthanh enhancingdocetaxelefficacyandreducingtoxicityusingbiodegradableperiodicmesoporousorganosilicananoparticles
AT minhtrile enhancingdocetaxelefficacyandreducingtoxicityusingbiodegradableperiodicmesoporousorganosilicananoparticles
AT tanlehoangdoan enhancingdocetaxelefficacyandreducingtoxicityusingbiodegradableperiodicmesoporousorganosilicananoparticles